Cassava Sciences Inc (NASDAQ:SAVA)

78.84
BATS BZX Real-Time Price
As of 1:39pm ET
 -1.43 / -1.78%
Today’s Change
2.58
Today|||52-Week Range
117.54
+1,056.01%
Year-to-Date
These 2 Biotech Stocks Are Up 1,000% This Year
Jun 16 / MotleyFool.com - Paid Partner Content
3 Drug Stocks Rise as FDA Okays Biogen Alzheimer's Drug
Jun 08 / Zacks.com - Paid Partner Content
Where Will Biogen Be in 1 Year?
Jun 15 / MotleyFool.com - Paid Partner Content
Why Cassava Sciences Was Up 15% in May
Jun 07 / MotleyFool.com - Paid Partner Content
Ignore Biogen: 3 Reasons These Stocks Will Be Better Alzheimer's Investments
Jun 11 / MotleyFool.com - Paid Partner Content
Forget Biogen: These 2 Alzheimer's Drug Stocks Could Make You Rich
Jun 07 / MotleyFool.com - Paid Partner Content
Urban Outfitters, Travelzoo, Eli Lilly, Cassava Sciences and Annovis Bio highlighted as Zacks Bull and Bear of the Day
Jun 09 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close80.27
Today’s open78.33
Day’s range78.23 - 82.75
Volume46,694
Average volume (3 months)2,857,297
Market cap$3.1B
Data as of 1:39pm ET, 06/17/2021

Growth & Valuation

Earnings growth (last year)+8.80%
Earnings growth (this year)+68.33%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book29.43

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo Therapeutics...+0.04+0.36%
RGNXRegenxbio Inc-0.72-1.88%
QUREUniqure NV-0.03-0.09%
AUPHAurinia Pharmaceutic...-0.14-1.11%
Data as of 1:39pm ET, 06/17/2021

Financials

Next reporting dateAugust 17, 2021
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$6.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Austin, Texas

Forecasts